Intestinal FXR signaling and induction of FGF15/19 were shown to dampen steatosis, inflammation, and fibrosis as mice deficient in FGF15 fed a HFD had severe steatohepatitis [174,175]. The gene discussed is NR1H4; the disease is steatosis.